Companies › KYMR

KYMERA THERAPEUTICS (KYMR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001815442 · EDGAR filings · Updated 2026-07-27

KYMERA THERAPEUTICS (KYMR) has reported institutional ownership of 117.1%, with 256 institutional managers holding positions valued at $8.01B per the latest 13F reporting period.

Filings this week (3)

• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-27 — Initial insider ownership filed (Form 3)
• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-07 — Insider transaction reported (Form 4)
• 2026-07-07 — Notice of proposed sale filed (Form 144)
• 2026-07-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, KYMERA THERAPEUTICS has 256 institutional holders and institutional ownership of 117.1%.

Insider activity

Insiders reported 137 transactions (7 buys, 92 sells) across 13 reporting insiders, with a net reported value of $136.4M.

Related companies

ICON PLC (ICLR) · SOLVENTUM CORP (SOLV) · PROTAGONIST THERAPEUTICS (PTGX) · HALOZYME THERAPEUTICS INC (HALO) · REPLIGEN CORP COM (RGEN) · ARROWHEAD PHARMACEUTICALS IN (ARWR)